Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06079294
NA

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Prospective cohort study evaluating FDG PET in 56 patients with confirmed autoimmune encephalitis - based on 2016 Graus criteria, and 2021 paraneoplastic neurological syndromes criteria - at the acute phase, before immunomodulating treatment, or within 10 days of treatment initiation.

Official title: Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism : a Prospective FDG PET Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2024-05-31

Completion Date

2026-05-31

Last Updated

2025-08-22

Healthy Volunteers

No

Interventions

OTHER

FDG PET

Brain FDG PET performed 3 months after treatment initiation

Locations (1)

Hospital Pitie Salpetriere

Paris, France